HealthcareServices

Global Diabetic Gastroparesis Treatment Market Report 2026–2035: Key Forecasts and Growth Areas

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the diabetic gastroparesis treatment market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Diabetic Gastroparesis Treatment Market between 2026 and 2030?

The market size for diabetic gastroparesis treatment has experienced robust expansion over recent years. This market is projected to expand from $4.05 billion in 2025 to $4.28 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.7%. Historically, this growth can be ascribed to several factors, including an increase in diabetes complications, a scarcity of traditional treatment avenues, higher rates of diagnosis, a dependence on pharmaceutical interventions, and the expansion of specialized gastroenterology care.

The market size for diabetic gastroparesis treatment is projected to experience substantial growth in the upcoming years. It is expected to expand to $5.47 billion by 2030, with a compound annual growth rate (CAGR) of 6.3%. This anticipated growth can be attributed to several factors including the development of innovative prokinetic agents, heightened awareness of the disease, the expansion of specialized clinics, a demand for sustained symptom management, and advancements in gastric stimulation technologies. Prominent trends within this forecast period include an increased reliance on prokinetic drug therapies, a rising emphasis on symptom-focused disease management, the proliferation of combination pharmacological treatments, an increasing adoption of minimally invasive interventions, and a greater focus on managing diet and lifestyle.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12580&type=smp

Which Drivers Are Expected To Impact The Diabetic Gastroparesis Treatment Market During The Forecast Period?

The escalating incidence of diabetes is projected to fuel the expansion of the diabetic gastroparesis treatment market in the coming years. Diabetes prevalence refers to the proportion or percentage of the populace diagnosed with diabetes at a particular moment. The application of diabetic gastroparesis treatment primarily aims to manage the symptoms and complications linked to this condition, which is a frequent consequence of diabetes. For instance, in April 2025, the International Diabetes Federation, a Belgium-based international not-for-profit federation of national diabetes associations, reported that an estimated 589 million adults aged 20–79 were living with diabetes globally, a figure expected to rise to 853 million by 2050. Consequently, the increasing prevalence of diabetes is a key factor driving the growth of the diabetic gastroparesis treatment market.

How Is The Diabetic Gastroparesis Treatment Market Divided Into Segments?

The diabetic gastroparesis treatment market covered in this report is segmented –

1) By Treatment: Medication, Surgery

2) By Route Of Administration: Oral, Injectables

3) By Indication: Compensated Gastroparesis, Gastric Failure

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Medication: Prokinetic Agents, Antiemetics, Antidepressants

2) By Surgery: Gastric Electrical Stimulation, Surgical Procedures For Gastric Drainage

Which Innovation Trends Are Advancing Developments Within The Diabetic Gastroparesis Treatment Market?

Leading companies in the diabetic gastroparesis treatment market are developing innovative solutions, such as small bowel intubation, to enhance diagnostic precision and treatment efficacy. Small bowel intubation involves placing a tube into the small intestine, enabling more accurate monitoring and therapeutic interventions for conditions like diabetic gastroparesis, where gastric motility is compromised. For instance, in September 2024, Avenacy, a US-based pharmaceutical company, launched Metoclopramide Injection (USP) in Unites States. Metoclopramide Injection (USP) is an injectable medication formulated for numerous indications, especially including the alleviation of symptoms linked to diabetic gastroparesis. It assists in preventing nausea and vomiting associated with chemotherapy and surgery. The injection facilitates small bowel intubation in situations where conventional techniques fail to guide a tube past the pylorus. It is also utilized to stimulate gastric emptying and accelerate barium transit during radiological procedures.

Which Key Players Are Driving Competition In The Diabetic Gastroparesis Treatment Market?

Major companies operating in the diabetic gastroparesis treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Ipca Laboratories Ltd., Abbott Laboratories, AstraZeneca plc, Medtronics plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Janssen Global Services LLC, Boston Scientific Corporation, Fresenius Kabi AG, Bausch Health Companies Inc., Salix Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Wockhardt Ltd., ANI Pharmaceuticals Inc., Endologic LLC, Vanda Pharmaceuticals Inc., Rhythm Pharmaceuticals Inc., Theravance Biopharma Inc., Neurogastrx Inc., Evoke Pharma Inc., CinRx Pharma LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/diabetic-gastroparesis-treatment-global-market-report

Which Region Is Projected To Lead The Diabetic Gastroparesis Treatment Market During The Forecast Period?

North America was the largest region in the diabetic gastroparesis treatment market in 2025, and is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic gastroparesis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Diabetic Gastroparesis Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12580&type=smp

Browse Through More Reports Similar to the Global Diabetic Gastroparesis Treatment Market 2026, By The Business Research Company

Diabetic Foot Ulcer Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-foot-ulcer-treatment-global-market-report

Gastroparesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Gastroparesis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795